<code id='692D2B9E46'></code><style id='692D2B9E46'></style>
    • <acronym id='692D2B9E46'></acronym>
      <center id='692D2B9E46'><center id='692D2B9E46'><tfoot id='692D2B9E46'></tfoot></center><abbr id='692D2B9E46'><dir id='692D2B9E46'><tfoot id='692D2B9E46'></tfoot><noframes id='692D2B9E46'>

    • <optgroup id='692D2B9E46'><strike id='692D2B9E46'><sup id='692D2B9E46'></sup></strike><code id='692D2B9E46'></code></optgroup>
        1. <b id='692D2B9E46'><label id='692D2B9E46'><select id='692D2B9E46'><dt id='692D2B9E46'><span id='692D2B9E46'></span></dt></select></label></b><u id='692D2B9E46'></u>
          <i id='692D2B9E46'><strike id='692D2B9E46'><tt id='692D2B9E46'><pre id='692D2B9E46'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:7
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          At ASCO, AstraZeneca reports strong data for breast cancer drug
          At ASCO, AstraZeneca reports strong data for breast cancer drug

          ThefuturelooksevenbrighterfortheblockbusterEnhertu,showcasedhereatASCO.ADAMFEUERSTEIN/STATCHICAGO—Th

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          FDA has safety concerns on CRISPR

          AdobeTheFoodandDrugAdministrationsaidonFridaythatithassomesafetyconcernsaboutanexperimentalCRISPR-ba